UnitedHealth Group Incorporated (NYSE:UNH) is Tokio Marine Asset Management Co. Ltd.’s 5th Largest Position

Tokio Marine Asset Management Co. Ltd. cut its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 1.1% during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 86,675 shares of the healthcare conglomerate’s stock after selling 971 shares during the quarter. UnitedHealth Group accounts for 2.2% of Tokio Marine Asset Management Co. Ltd.’s portfolio, making the stock its 5th biggest holding. Tokio Marine Asset Management Co. Ltd.’s holdings in UnitedHealth Group were worth $50,677,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently bought and sold shares of UNH. Kathleen S. Wright Associates Inc. acquired a new position in shares of UnitedHealth Group in the third quarter worth $27,000. Macroview Investment Management LLC grew its position in shares of UnitedHealth Group by 671.4% in the second quarter. Macroview Investment Management LLC now owns 54 shares of the healthcare conglomerate’s stock valued at $28,000 after purchasing an additional 47 shares during the period. Delos Wealth Advisors LLC grew its holdings in UnitedHealth Group by 757.1% in the 1st quarter. Delos Wealth Advisors LLC now owns 60 shares of the healthcare conglomerate’s stock valued at $30,000 after buying an additional 53 shares during the period. Bbjs Financial Advisors LLC acquired a new stake in shares of UnitedHealth Group during the 2nd quarter worth $31,000. Finally, Global Wealth Strategies & Associates grew its position in UnitedHealth Group by 152.4% during the third quarter. Global Wealth Strategies & Associates now owns 53 shares of the healthcare conglomerate’s stock valued at $31,000 after acquiring an additional 32 shares during the period. Institutional investors and hedge funds own 87.86% of the company’s stock.

UnitedHealth Group Stock Performance

Shares of NYSE UNH traded down $2.97 during midday trading on Thursday, hitting $602.90. 152,348 shares of the company’s stock were exchanged, compared to its average volume of 3,877,487. UnitedHealth Group Incorporated has a twelve month low of $436.38 and a twelve month high of $630.73. The firm has a market cap of $554.84 billion, a P/E ratio of 39.47, a PEG ratio of 1.80 and a beta of 0.58. The stock’s 50 day moving average price is $582.99 and its 200-day moving average price is $548.03. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.91 and a quick ratio of 0.91.

UnitedHealth Group (NYSE:UNH) last released its earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 EPS for the quarter, beating the consensus estimate of $7.00 by $0.15. The firm had revenue of $100.82 billion for the quarter, compared to analysts’ expectations of $99.14 billion. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. UnitedHealth Group’s quarterly revenue was up 9.2% on a year-over-year basis. During the same quarter last year, the company earned $6.56 EPS. Equities research analysts anticipate that UnitedHealth Group Incorporated will post 27.61 EPS for the current year.

UnitedHealth Group Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Tuesday, December 17th. Stockholders of record on Monday, December 9th will be given a dividend of $2.10 per share. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.39%. The ex-dividend date of this dividend is Monday, December 9th. UnitedHealth Group’s dividend payout ratio (DPR) is presently 54.72%.

Analyst Ratings Changes

UNH has been the topic of a number of recent research reports. Royal Bank of Canada reduced their price target on shares of UnitedHealth Group from $615.00 to $595.00 and set an “outperform” rating on the stock in a research report on Wednesday, October 16th. Hsbc Global Res downgraded UnitedHealth Group from a “strong-buy” rating to a “hold” rating in a report on Thursday, October 17th. Wells Fargo & Company raised their target price on UnitedHealth Group from $525.00 to $630.00 and gave the company an “overweight” rating in a report on Wednesday, July 17th. Jefferies Financial Group upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating and upped their target price for the company from $481.00 to $647.00 in a research note on Wednesday, July 17th. Finally, HSBC downgraded UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Thursday, October 17th. Three research analysts have rated the stock with a hold rating, eighteen have assigned a buy rating and two have assigned a strong buy rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $615.53.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.